Table 5.
Clinicopathologic parameters | Outcome
|
P-value | |
---|---|---|---|
Remission | Relapse | ||
Sex | 0.295 | ||
Male | 20 | 5 | |
Female | 20 | 2 | |
Age (years) | 0.727 | ||
≤40 | 20 | 3 | |
>40 | 20 | 4 | |
WBC count (×109/L) | 0.492 | ||
≤5 | 33 | 5 | |
>5 | 7 | 2 | |
Platelet count (×109/L) | 0.331 | ||
≤40 | 27 | 6 | |
>40 | 13 | 1 | |
Hemoglobin (g/L) | 0.086 | ||
<100 | 30 | 3 | |
≥100 | 10 | 4 | |
Maintenance regimens | 0.007 | ||
ATRA+As2O3 | 22 | 0 | |
ATRA+chemotherapy | 18 | 7 |
Abbreviations: APL, acute promyelocytic leukemia; As2O3, arsenic trioxide; ATRA, all-trans retinoic acid; IDA, idarubicin; WBC, white blood cell.